icon-folder.gif   Conference Reports for NATAP  
 
  AASLD
The Liver Meeting
Boston MA
November 2016		 Back grey_arrow_rt.gif
 
 
 
Exploring Combination Therapy for Curing HBV - Preclinical Combo
Studies with Capsid Inhibitor AB-423 and siRNA Agent ARB-1740
 
 
  Reported by Jules Levin
AASLD 2016 Nov 11-15 Boston, MA

HCV1

HCV2

HCV3

HCV4

HCV5

HCV6

HCV7